Physician profile
Lynette Cacciotti
NPI 1578619151
$8,543.54
in general payments reported to CMS, 2019-2025
16 companies · $1,807 in 2025
The $1,807 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,353 · 2020: $1,197 · 2021: $1,040 · 2022: $1,520 · 2023: $1,094 · 2024: $533 · 2025: $1,807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,248 · Consulting Fee: $165 · Entertainment: $20.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,248.21 |
| Consulting Fee | $165.00 |
| Entertainment | $20.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,395.44 | 2019-2025 | Precision 1, Dailies Total1, Hydrus Microstent |
| Coopervision INC. | $1,452.56 | 2020-2025 | Myday Contact Lens, Misight Contact Lens, Ortho-K Contact Lens |
| Glaukos Corporation | $959.59 | 2022-2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Johnson & Johnson Vision Care, INC. | $798.24 | 2021-2024 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $408.14 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $310.68 | 2021-2025 | |
| Oyster Point Pharma, INC. | $287.10 | 2022-2023 | Tyrvaya |
| Abb Con-Cise Optical Group LLC | $223.55 | 2019-2025 | Contact Lens, Spectacle Lenses |
| Bausch & Lomb Americas INC. | $199.18 | 2024-2025 | Miebo, Xiidra, Biotrue One Day |
| Sight Sciences, INC. | $149.96 | 2023 | Omni Surgical System |
| Johnson & Johnson Surgical Vision, INC. | $140.14 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $121.70 | 2019 | |
| Optos, INC. | $41.99 | 2021-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Tarsus Pharmaceuticals, INC. | $22.58 | 2024 | Xdemvy |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.45 | 2023 | Alphagan P, Lumigan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynette Cacciotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.